You are here: Industry Insights > COVID-19

News List

Positive top line data released for study of C21 in COVID-19 patients europeanpharmaceuticalreview
December 10, 2020
In hospitalised COVID-19 patients, researchers found that C21 reduced the risk of needing oxygen at the end of treatment by 40 percent.
Cepheid Receives CE-IVD Registration for SARS-CoV-2, Flu A, Flu B, RSV Combination Test americanpharmaceuticalreview
December 10, 2020
Cepheid announced the CE-IVD marking of Xpert? Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample.
Hyundai Bioscience announced that its COVID-19 oral drug solved Niclosamide's inhibitory concentration problem prnewswire
December 09, 2020
Hyundai Bioscience released a report on December 8th that CP-COV03, its new COVID-19 oral drug candidate, successfully demonstrated a 100% inhibitory concentration level in the blood (IC100) for 12 hours against viral activity with a single ...
Liquid Diagnostics Develops Unique Saliva COVID-19 Antibody Test prnewswire
December 09, 2020
Liquid Diagnostics announced today the development and successful CLIA validation of a home-collection assay for the quantitative testing of COVID-19 antibodies using saliva.
Potential Treatment from ARCA for COVID-19 Receives Fast Track Designation americanpharmaceuticalreview
December 09, 2020
ARCA biopharma announced the U.S. Food and Drug Administration (FDA) has designated as a Fast Track development program the investigation of AB201 as a potential treatment for COVID-19.
Sotira Completes Pre-Clinical Testing for COVID-19 Vaccine Alternative americanpharmaceuticalreview
December 09, 2020
Sotira has announced the successful completion of the second phase of pre-clinical testing for its COVID-19 therapeutic and vaccine-alternative, KEPTIDE? COVID, confirming this molecular therapy completely prevented the entry of SARS-CoV2 in the lungs ...
NIAID Selects Metabolon for COVID-19 Study americanpharmaceuticalreview
December 09, 2020
Metabolon will participate in the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, Immunophenotyping Assessment in a COVID-19 Cohort, or IMPACC, study (grant no: 5U19AI118602-04).
Inovio initiates dosing in Phase II segment of Covid-19 therapy trial pharmaceutical-technology
December 09, 2020
Biotechnology firm Inovio has dosed the first participant in a Phase II segment of its Phase II / III INovio INO-4800 Vaccine Trial for Efficacy (INNOVATE) trial analysing its Covid-19 vaccine candidate, INO-4800.
UK becomes first country to initiate Covid-19 vaccination pharmaceutical-technology
December 09, 2020
The United Kingdom (UK) has started administering the Covid-19 vaccine, developed by Pfizer and its German partner BioNTech, outside a clinical trial, becoming the first country in the world to administer the new vaccine.
HALIX, AstraZeneca Ink Commercial COVID-19 Vax Mfg. Pact contractpharma
December 09, 2020
HALIX to provide large-scale GMP manufacture of AZD1222 at its cGMP facility in the Netherlands.